|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0784 | (2010.01) |
| C07K 14/525 | (2013.01) | ||
| C12N 5/02 | (2006.01) | ||
| C07K 14/5412 | (2013.01) | ||
| C07K 14/535 | (2006.01) | ||
| C07K 14/5421 | (2013.01) | ||
| C07K 14/54 | (2006.01) | ||
| C07K 14/5434 | (2013.01) | ||
| C12N 5/0639 | (2013.01) | ||
| C07K 14/57 | (2006.01) | ||
| C07K 14/525 | (2006.01) | ||
| C12N2500/72 | (2013.01) | ||
| A61K 35/15 | (2015.01) | ||
| C12N2501/22 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| G01N 33/5023 | (2013.01) | ||
| G01N 33/569 | (2006.01) | ||
| G01N 33/5047 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/56972 | (2013.01) | ||
| G01N 33/6869 | (2013.01) | ||
| G01N2333/5255 | (2013.01) | ||
| G01N2333/5412 | (2013.01) | ||
| G01N2333/5421 | (2013.01) | ||
| G01N2333/5434 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| A61K 35/15 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3350318 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16847253.8 |
| Date of filing the European patent application | 2016-09-14 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/051781 |
| Date | 2016-09-14 |
| (87) | Number | WO 2017/048875 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| 201562219058 P | 2015-09-15 | US |
| (72) |
BOSCH, Marnix, L. , US
|
| (73) |
NorthWest Biotherapeutics, Inc. ,
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814,
US
|
| (54) | METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS FOR SUBJECTS WITH ADVANCED CANCERS |
| METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS FOR SUBJECTS WITH ADVANCED CANCERS |